Candidiasis

IDSA Candidiasis

IDSA Candidiasis GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/102824

Contents of this Issue

Navigation

Page 6 of 9

Candida vulvovaginitis Topical agents (see table below) or fluconazole (Diflucan) 150 mg single dose for uncomplicated vaginitis (A-I) Recurrent vulvovaginal candidiasis (VVC) is managed with fluconazole (Diflucan) 150 mg weekly for 6 months, following initial control of the recurrent episode Intravaginal Agents Gynazole-1 (butoconazole) 2% cream 5 g intravaginally x 1 or 3 days Gynazole-1 (butoconazole) 2% cream 5 g (butoconazole-sustained release) single intravaginal application Clotrimazole 1% cream 5 g intravaginally for 7-14 days Gyne-Lotrimin 7 (clotrimazole) 100 mg vaginal tablet for 7 days Gyne-Lotrimin 3 (clotrimazole) 200 mg vaginal tablet for 3 days Monistat (miconazole) 2% cream 5 g intravaginally for 7 days Miconazole 100 mg vaginal suppository, one suppository for 7 days Monistat 3 (miconazole) 200 mg vaginal suppository daily x 3 days Monistat 1 (miconazole) 1,200 mg vaginal suppository for 1 day Nystatin 100,000-unit vaginal tablet, one tablet for 14 days Vagistat-1 (tioconazole) 6.5% ointment 5 g intravaginally x 1 Terazol 7 (terconazole) 0.4% cream 5 g intravaginally for 7 days Terazol 3 (terconazole) 0.8% cream 5 g intravaginally for 3 days Terconazole 80 mg vaginal suppository, one suppository for 3 days Neonatal Candidiasis AmB-d 1 mg/kg daily (A-II) or fluconazole 12 mg/kg daily (B-II) for 3 wks LFAmB 3-5 mg/kg daily (B-III) A lumbar puncture and dilated retinal examination should be performed on all neonates with suspected invasive candidiasis. Intravascular catheter removal is strongly recommended. Duration of therapy is at least 3 wks. LFAmB used only if there is no renal involvement. Echinocandins should be used with caution and only when other agents cannot be used. Esophageal Candidiasis Primary Primary Treatment Fluconazole 200-400 mg (3-6 mg/kg) daily (A-I) Unable to tolerate Oral Therapy An echinocandin**; or AmB-d 0.3-0.7 mg/kg daily (B-II) Fluconazole-Refractory Itraconazole oral solution 200 mg daily; or posaconazole suspension 400 mg bid; or voriconazole 200 mg IV or PO bid (A-III) x 14-21 d. Alternative Micafungin 150 mg daily, caspofungin 50 mg daily, anidulafungin 200 mg daily or AmB-d 0.3-0.7 mg/kg daily. **Echinocandin dosing in adults is anidulafungin, 200 mg loading then 100 mg/d, caspofungin, 70 mg loading then 50 mg/d, and micafungin, 100 mg/d.

Articles in this issue

Archives of this issue

view archives of Candidiasis - IDSA Candidiasis